Nabsys, founded in Providence, United States, is a life sciences company dedicated to advancing genomic research through its innovative solid-state, single-molecule positional sequencing technology. The company's core mission is to revolutionize genomic analysis by providing high-resolution, accurate, and cost-effective sequencing solutions. Nabsys offers a range of products including the OhmX Analyzer™, OhmX Sample Prep Kit, OhmX-8 Detector, and Human Chromosome Explorer™, catering to markets such as functional genomics, clinical research, rare disease, cancer research, precision medicine, and cell and gene therapy.
Notable figures associated with Nabsys include experienced professionals in genomics and biotechnology sectors. The company has garnered significant investment from leading venture capital firms and has achieved key milestones in the development and commercialization of its sequencing technology. Nabsys' impact is evident in its contributions to precision medicine and emerging genomic technologies, positioning it as a pivotal player in the life sciences industry.